Mark A Agius Selected Research

Mark A Agius Research Topics

6	Multiple Sclerosis 01/2020 - 01/2011
4	Myasthenia Gravis 12/2012 - 09/2003
2	Relapsing-Remitting Multiple Sclerosis 01/2020 - 06/2014
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2020
1	Fever (Fevers) 01/2019
1	Urinary Tract Infections (Urinary Tract Infection) 01/2019
1	Neoplasms (Cancer) 06/2014
1	Bradycardia 06/2014
1	Basal Cell Carcinoma (Rodent Ulcer) 06/2014
1	Atrioventricular Block 06/2014
1	Herpes Zoster 06/2014
1	Hypertension (High Blood Pressure) 06/2014
1	Infections 06/2014
1	Lymphopenia (Lymphocytopenia) 06/2014
1	Autoimmune Diseases (Autoimmune Disease) 03/2014
1	Inflammation (Inflammations) 03/2014
1	Thymus Hyperplasia 12/2012
1	Muscle Weakness 04/2012
1	Weight Loss (Weight Reduction) 04/2012
1	Disease Progression 12/2004

3	AntigensIBA 03/2014 - 09/2003
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2011
2	Phosphotransferases (Kinase)IBA 12/2012 - 04/2012
2	muskIBA 12/2012 - 04/2012
2	AntibodiesIBA 04/2012 - 12/2003
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 12/2003 - 09/2003
1	Interferon beta-1a FDA Link 01/2020
1	Alemtuzumab (Campath)FDA Link 01/2020
1	Inosine Triphosphate (ITP)IBA 01/2020
1	Monoclonal AntibodiesIBA 01/2019
1	inebilizumabIBA 01/2019
1	Alanine Transaminase (SGPT)IBA 06/2014
1	Fingolimod Hydrochloride (FTY720)FDA Link 06/2014
1	Adrenocorticotropic Hormone (ACTH)FDA Link 03/2014
1	Indicators and Reagents (Reagents)IBA 03/2014
1	CytokinesIBA 03/2014
1	HLA-DRB5 Chains (HLA DRB5)IBA 04/2013
1	HLA-DRB1 Chains (HLA DRB1)IBA 04/2013
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 12/2012
1	Proteins (Proteins, Gene)FDA Link 04/2012
1	Cholinergic ReceptorsIBA 04/2012
1	Recombinant DNA (Recombinant DNA Research)IBA 01/2011

2	Therapeutics 01/2020 - 12/2004
1	Immunotherapy 03/2014